Skip to content

PHARGEST: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

PHARGEST

BE 0449.558.574
NACE 47.730, Retail sale of pharmaceutical products
fiscal year 2024 against 2025filed annual accounts (NBB)
Net result for the year
€57,206
2024 · €92,062-€34,856
Equity
€871,154
2024 · €813,949+€57,206
Cash
€233,280
2024 · €303,651-€70,371
Balance sheet total
€1.8m
2024 · €1.7m+€43,271

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€154,564

    up €154,564 (+20.9%), from €740,962 to €895,526

    of which Assets under construction and advance payments: +€212,014

  • Cash -€70,371

    down €70,371 (-23.2%), from €303,651 to €233,280

    mainly Investment in fixed assets (net) (-€244,437) and Other debts (-€39,893)

  • Stocks and contracts -€62,749

    down €62,749 (-12.1%), from €518,418 to €455,669

  • Receivables within one year +€22,120

    up €22,120 (+13.7%), from €161,801 to €183,921

    of which Other amounts receivable: +€14,779

Equity and liabilities
  • Reserves +€57,100

    up €57,100 (+10.2%), from €560,290 to €617,390

    of which Non-distributable reserves: +€57,100

  • Other debts -€39,893

    down €39,893 (-9.6%), from €416,918 to €377,025

  • Trade debts +€34,631

    up €34,631 (+12.8%), from €270,455 to €305,085

  • Debts after one year -€18,902

    down €18,902 (-21.2%), from €89,032 to €70,131

    of which Financial debts: -€19,202

Income statement
  • Staff costs +€36,770

    up €36,770 (+8.0%), from €461,256 to €498,026

  • Gross operating margin -€21,031

    down €21,031 (-2.9%), from €737,898 to €716,867

  • Taxes -€17,007

    down €17,007 (-37.9%), from €44,925 to €27,918

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €92,062
Gross operating margin -€21,031
Staff costs -€36,770
Depreciation +€3,921
Other operating charges -€349
Financial income -€1,063
Financial charges +€3,429
Taxes +€17,007
Result 2025 €57,206

Cash bridge derived

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€179,778
Investment -€244,742
Financing -€5,407
Cash 2024 €303,651
Net result for the year +€57,206
Depreciation +€90,190
Stocks and contracts +€62,749
Receivables within one year -€22,120
Deferred charges and accrued income +€281
Trade debts +€34,631
Tax, wage and social debts -€4,346
Other debts -€39,893
Accrued charges and deferred income +€1,081
Investment in fixed assets (net) -€244,437
Current investments -€305
Debts after one year -€18,902
Current portion of long-term debt +€49
Short-term financial debts +€13,445
Cash 2025 €233,280
Every line side by side 63 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,737,237 €1,780,509 +€43,271 +2.5%
Fixed assets 21/28 €742,241 €896,488 +€154,247 +20.8%
Intangible fixed assets 21 €1,229 €912 -€317 -25.8%
Tangible fixed assets 22/27 €740,962 €895,526 +€154,564 +20.9%
Land and buildings 22 €544,766 €511,997 -€32,769 -6.0%
Plant, machinery and equipment 23 €79,774 €65,292 -€14,482 -18.2%
Furniture and vehicles 24 €22,135 €17,382 -€4,754 -21.5%
Leasing and similar rights 25 €5,207 €2,603 -€2,603 -50.0%
Other tangible fixed assets 26 €89,079 €86,238 -€2,842 -3.2%
Assets under construction and advance payments 27 - €212,014 +€212,014
Financial fixed assets 28 €50 €50 = 0.0%
Current assets 29/58 €994,996 €884,021 -€110,976 -11.2%
Stocks and contracts in progress 3 €518,418 €455,669 -€62,749 -12.1%
Stocks 30/36 €518,418 €455,669 -€62,749 -12.1%
Amounts receivable within one year 40/41 €161,801 €183,921 +€22,120 +13.7%
Trade receivables 40 €153,212 €160,553 +€7,341 +4.8%
Other amounts receivable 41 €8,589 €23,368 +€14,779 +172.1%
Current investments 50/53 €3,203 €3,508 +€305 +9.5%
Cash at bank and in hand 54/58 €303,651 €233,280 -€70,371 -23.2%
Deferred charges and accrued income 490/1 €7,923 €7,642 -€281 -3.5%
Total equity and liabilities 10/49 €1,737,237 €1,780,509 +€43,271 +2.5%
Equity 10/15 €813,949 €871,154 +€57,206 +7.0%
Contributions 10/11 €62,650 €62,650 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Outside capital 11 €650 €650 = 0.0%
Share premium 1100/10 €650 €650 = 0.0%
Reserves 13 €560,290 €617,390 +€57,100 +10.2%
Non-distributable reserves 130/1 €469,350 €526,450 +€57,100 +12.2%
Legal reserve 130 €6,200 €6,200 = 0.0%
Reserves not available under the articles 1311 €463,150 €520,250 +€57,100 +12.3%
Tax-exempt reserves 132 €74,940 €74,940 = 0.0%
Distributable reserves 133 €16,000 €16,000 = 0.0%
Profit (loss) carried forward 14 €191,008 €191,114 +€106 +0.1%
Amounts payable 17/49 €923,289 €909,354 -€13,934 -1.5%
Amounts payable after more than one year 17 €89,032 €70,131 -€18,902 -21.2%
Financial debts 170/4 €85,832 €66,631 -€19,202 -22.4%
Other amounts payable 178/9 €3,200 €3,500 +€300 +9.4%
Amounts payable within one year 42/48 €811,663 €815,549 +€3,886 +0.5%
Current portion of amounts payable after more than one year 42 €19,152 €19,202 +€49 +0.3%
Financial debts 43 - €13,445 +€13,445
Credit institutions 430/8 - €13,445 +€13,445
Trade debts 44 €270,455 €305,085 +€34,631 +12.8%
Suppliers 440/4 €270,455 €305,085 +€34,631 +12.8%
Taxes, remuneration and social security 45 €105,138 €100,791 -€4,346 -4.1%
Taxes 450/3 €34,980 €31,527 -€3,453 -9.9%
Remuneration and social security 454/9 €70,157 €69,264 -€893 -1.3%
Other amounts payable 47/48 €416,918 €377,025 -€39,893 -9.6%
Accrued charges and deferred income 492/3 €22,594 €23,675 +€1,081 +4.8%
Remuneration, social security and pensions 62 €461,256 €498,026 +€36,770 +8.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €94,111 €90,190 -€3,921 -4.2%
Other operating charges 640/8 €9,723 €10,072 +€349 +3.6%
Gross operating margin 9900 €737,898 €716,867 -€21,031 -2.9%
Operating profit (loss) 9901 €172,807 €118,578 -€54,229 -31.4%
Financial income 75/76B €1,340 €278 -€1,063 -79.3%
Recurring financial income 75 €1,340 €278 -€1,063 -79.3%
Financial charges 65/66B €37,160 €33,731 -€3,429 -9.2%
Recurring financial charges 65 €37,160 €33,731 -€3,429 -9.2%
Profit (loss) for the period before taxes 9903 €136,987 €85,124 -€51,863 -37.9%
Income taxes 67/77 €44,925 €27,918 -€17,007 -37.9%
Profit (loss) for the period 9904 €92,062 €57,206 -€34,856 -37.9%
Transfer to tax-exempt reserves 689 €0 - =
Profit (loss) for the period to be appropriated 9905 €92,062 €57,206 -€34,856 -37.9%

Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 6 October 2026 via checked.be.